- 0
- 214 words
WASHINGTON — The White House is dropping Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed Tuesday.
\n\nThe decision comes a day before the Senate Health Committee was scheduled to vote on whether to advance her nomination to the full Senate for confirmation.
\n\nAxios first reported the White House’s decision.
\n\nThe move follows weeks of doubts from key Republicans on the Health, Education, Pensions and Labor Committee. To advance to the full Senate, Overton would have needed 11 votes in the 21-member committee, meaning she couldn’t afford to lose a single Republican if all Democrats opposed her.
\n\nSen. Bill Cassidy of Louisiana, the committee’s chairman, questioned whether Overton — a preventive medicine doctor who serves as a domestic policy official in the White House — had enough experience to lead the agency.
\n\nBefore Overton’s confirmation hearing in September, Cassidy wrote on X that he had “strong concerns” about her nomination, saying her lack of managerial experience left her poorly prepared to lead the agency. In a post last week, Cassidy said he remained undecided.
\n\nPrior to joining the White House, Overton worked as chief policy officer at the conservative think tank America First…
Original source: https://www.nbcnews.com/health
